A2B ADENOSINE RECEPTOR ANTAGONISTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130123280A1
SERIAL NO

13666826

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GILEAD SCIENCES INC333 LAKESIDE DRIVE FOSTER CITY CA 94404

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elzein, Elfatih Fremont, US 99 812
Ibrahim, Prabha N Mountain View, US 139 6477
Kalla, Rao V Cupertino, US 32 183
Li, Xiaofen Mountain View, US 53 529
Palle, Venkata Kharadi Pune, IN 48 354
Perry, Thao San Jose, US 42 484
Varkhedkar, Vaibhav Chalfont, US 29 304
Xiao, Dengming Longmont, US 62 615
Zablocki, Jeff Los Altos, US 176 1646

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation